Abstract | PURPOSE: METHODS: Between November 2013 and October 2014, 26 patients with VN were prospectively enrolled in this study. The patients were randomly assigned to treatment with a combination of 20 mg/d of intravenous metoclopramide, 100 mg of oral dimenhydrinate, and 5 mg/d of intravenous DEX or 20 mg/d of intravenous metoclopramide, 100 mg of oral dimenhydrinate, and intravenous normal saline as a placebo therapy. Patients' subjective assessments of the severity of their nausea and dizziness were recorded using a visual analog scale on the day of admission and 2 days, 3 days, 1 month, and 3 months thereafter. Bedside examinations consisted of spontaneous nystagmus (SPN) assessment, the head shaking nystagmus test, and the head impulse test, which were performed at every follow-up visit. FINDINGS: The severity of nausea and dizziness was significantly reduced over time (both P < 0.05). However, there was no significant effect of DEX injection on the severity of nausea or dizziness (P > 0.05). The presence of SPN was solely associated with nausea (hazard ratio = 3.34; 95% CI, 1.85-6.02). IMPLICATIONS: The administration of intravenous DEX did not relieve nausea or dizziness any better than a placebo treatment. However, further research is required to confirm whether there is a dose-dependent effect of DEX on the control of nausea or dizziness in VN.
|
Authors | Ji Chan Kim, Wang Woon Cha, Dong Sik Chang, Ho Yun Lee |
Journal | Clinical therapeutics
(Clin Ther)
Vol. 37
Issue 11
Pg. 2536-42
(Nov 01 2015)
ISSN: 1879-114X [Electronic] United States |
PMID | 26475420
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2015 Elsevier HS Journals, Inc. All rights reserved. |
Chemical References |
- Dexamethasone
- Metoclopramide
|
Topics |
- Administration, Intravenous
- Adult
- Aged
- Aged, 80 and over
- Dexamethasone
(administration & dosage)
- Dizziness
(drug therapy, etiology)
- Female
- Humans
- Male
- Metoclopramide
(administration & dosage)
- Middle Aged
- Nausea
(drug therapy, etiology)
- Prospective Studies
- Vestibular Neuronitis
(drug therapy)
|